Assembly Biosciences(us:ASMB)

18.12

+4.68%

Updated on 2025-06-30

Open:17.72
Close:18.12
High:18.50
Low:17.55
Prev Close:17.31
Volume:91781.00
Turnover:1.66M
Turnover Ratio:1.20%
Shares:7.64M
MarketCap:138.39M
CodeChg %RPS5RPS10RPS15RPS20TotalIncreaseDecrease
+0.05%25938896653287335

About

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Address:Two Tower Place,7th floor

Market Movers